An overview of the biochemistry, synthesis, modification, and evaluation of mucoadhesive polymeric nanoparticles for oral delivery of bioactive compounds
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Oral and gingival health research · Carbohydrate Chemistry and Synthesis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Hu Q et al (2019) Biocompatible polymeric nanoparticles with exceptional gastrointestinal stability as oral delivery vehicles for lipophilic bioactives. Food Hydrocoll 89:386–39510.1016/j.foodhyd.2018.10.057 ↗
2. Jachak A et al (2012) Transport of metal oxide nanoparticles and single-walled carbon nanotubes in human mucus. Nanotoxicology 6(6):614–62210.3109/17435390.2011.598244 ↗
3. Lai SK et al (2009) Micro-and macrorheology of mucus. Adv Drug Deliv Rev 61(2):86–10010.1016/j.addr.2008.09.012 ↗
4. Lai SK, Wang Y-Y, Hanes J (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 61(2):158–17110.1016/j.addr.2008.11.002 ↗
5. McAuley JL et al (2007) MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Investig 117(8):2313–232410.1172/JCI26705 ↗
6. Smart JD (2005) The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 57(11):1556–156810.1016/j.addr.2005.07.001 ↗
7. Ensign LM et al (2012) Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery. Adv Mater 24(28):3887–389410.1002/adma.201201800 ↗
8. Varum FJ et al (2010) An investigation into the role of mucus thickness on mucoadhesion in the gastrointestinal tract of pig. Eur J Pharm Sci 40(4):335–34110.1016/j.ejps.2010.04.007 ↗
9. Hanafy NA, Leporatti S, El-Kemary MA (2019) Mucoadhesive hydrogel nanoparticles as smart biomedical drug delivery system. Appl Sci 9(5):82510.3390/app9050825 ↗
10. Allen A (1983) Mucus—a protective secretion of complexity. Trends Biochem Sci 8(5):169–17310.1016/0968-0004(83)90166-4 ↗
11. Korjamo T, Heikkinen AT, Mönkkönen J (2009) Analysis of unstirred water layer in in vitro permeability experiments. J Pharm Sci 98(12):4469–447910.1002/jps.21762 ↗
12. Allen A et al (1990) The adherent gastric mucus gel barrier in man and changes in peptic ulceration. J Intern Med 228(S732):83–9010.1111/j.1365-2796.1990.tb01477.x ↗
13. Kerss S, Allen A, Garner A (1982) A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. Clin Sci 63(2):187–19510.1042/cs0630187 ↗
14. Sönju T et al (1974) Electron microscopy, carbohydrate analyses and biological activities of the proteins adsorbed in two hours to tooth surfaces in vivo. Caries Res 8(2):113–12210.1159/000260099 ↗
15. Accili D et al (2004) Mucoadhesion dependence of pharmaceutical polymers on mucosa characteristics. Eur J Pharm Sci 22(4):225–23410.1016/j.ejps.2003.12.011 ↗
16. Min S, Kim S, Cho S-W (2020) Gastrointestinal tract modeling using organoids engineered with cellular and microbiota niches. Exp Mol Med 52(2):227–23710.1038/s12276-020-0386-0 ↗
17. Cone RA (2009) Barrier properties of mucus. Adv Drug Deliv Rev 61(2):75–8510.1016/j.addr.2008.09.008 ↗
18. Bernkop-Schnürch A (2005) Mucoadhesive systems in oral drug delivery. Drug Discov Today Technol 2(1):83–8710.1016/j.ddtec.2005.05.001 ↗
19. Bansil R, Turner BS (2006) Mucin structure, aggregation, physiological functions and biomedical applications. Curr Opin Colloid Interface Sci 11(2–3):164–17010.1016/j.cocis.2005.11.001 ↗
20. Ensign LM, Cone R, Hanes J (2012) Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev 64(6):557–57010.1016/j.addr.2011.12.009 ↗
21. Andrews GP, Laverty TP, Jones DS (2009) Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm 71(3):505–51810.1016/j.ejpb.2008.09.028 ↗
22. Carlstedt I, Sheehan JK (1984) Is the macromolecular architecture of cervical, respiratory and gastric mucins the same? Portland Press Ltd10.1042/bst0120615 ↗
23. Lai SK et al (2007) Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc Natl Acad Sci 104(5):1482–148710.1073/pnas.0608611104 ↗
24. Griffiths PC et al (2015) Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering. Eur J Pharm Biopharm 97:218–22210.1016/j.ejpb.2015.05.004 ↗
25. Macao B et al (2006) Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat Struct Mol Biol 13(1):71–7610.1038/nsmb1035 ↗
26. Johansson ME, Sjövall H, Hansson GC (2013) The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10(6):352–36110.1038/nrgastro.2013.35 ↗
27. Kinloch A (1980) The science of adhesion. J Mater Sci 15(9):2141–216610.1007/BF00552302 ↗
28. Shaikh R et al (2011) Mucoadhesive drug delivery systems. Journal of pharmacy and Bioallied Sciences 3(1):8910.4103/0975-7406.76478 ↗
29. Das Neves J et al (2011) Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale. Expert Opin Drug Deliv 8(8):1085–110410.1517/17425247.2011.586334 ↗
30. Allen K (1987) A review of contemporary views of theories of adhesion. J Adhes 21(3–4):261–27710.1080/00218468708074974 ↗
31. Sharpe LH (1972) The interphase in adhesion. J Adhes 4(1):51–6410.1080/00218467208072210 ↗
32. Hntsberger J (1981) Surface energy, wetting and adhesion. J Adhes 12(1):3–1210.1080/00218468108071184 ↗
33. Fourche G (1995) An overview of the basic aspects of polymer adhesion. Part I: fundamentals. Polym Eng Sci 35(12):957–96710.1002/pen.760351202 ↗
34. Voyutskiĭ S (1960) The diffusion theory of adhesion. Rubber Chem Technol 33(3):748–75610.5254/1.3542193 ↗
35. Williams M (1969) The continuum interpretation for fracture and adhesion. J Appl Polym Sci 13(1):29–4010.1002/app.1969.070130105 ↗
36. Lehr C-M, Haas J (2002) Developments in the area of bioadhesive drug delivery systems. Expert Opin Biol Ther 2(3):287–29810.1517/14712598.2.3.287 ↗
37. Ponchel G et al (1997) Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur J Pharm Biopharm 44(1):25–3110.1016/S0939-6411(97)00098-2 ↗
38. Laffleur F et al (2017) Comprehensive mucoadhesive study of anionic polymers and their derivate. Eur Polymer J 93:314–32210.1016/j.eurpolymj.2017.06.012 ↗
39. HäGerström H, Edsman K, Strømme M (2003) Low-frequency dielectric spectroscopy as a tool for studying the compatibility between pharmaceutical gels and mucous tissue. J Pharm Sci 92(9):1869–188110.1002/jps.10451 ↗
40. Abdelfatah E et al (2017) Study of nanoparticle adsorption and release in porous media based on the DLVO theory. in SPE Latin America and Caribbean Petroleum Engineering Conference. OnePetro10.2118/185484-MS ↗
41. Adamczyk Z, Weroński P (1999) Application of the DLVO theory for particle deposition problems. Adv Coll Interface Sci 83(1–3):137–22610.1016/S0001-8686(99)00009-3 ↗
42. Fabiano A, Zambito Y, Bernkop-Schnürch A (2017) About the impact of water movement on the permeation behaviour of nanoparticles in mucus. Int J Pharm 517(1–2):279–28510.1016/j.ijpharm.2016.12.024 ↗
43. Froehlich E, Roblegg E (2014) Mucus as barrier for drug delivery by nanoparticles. J Nanosci Nanotechnol 14(1):126–13610.1166/jnn.2014.9015 ↗
44. Alp G, Aydogan N (2020) Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer. Eur J Pharm Biopharm 149:45–5710.1016/j.ejpb.2020.01.017 ↗
45. He P, Davis SS, Illum L (1998) In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 166(1):75–8810.1016/S0378-5173(98)00027-1 ↗
46. Tur KM, Ch’ng H-S (1998) Evaluation of possible mechanism (s) of bioadhesion. Int J Pharm 160(1):61–7410.1016/S0378-5173(97)00297-4 ↗
47. Degim Z, Kellaway I (1998) An investigation of the interfacial interaction between poly (acrylic acid) and glycoprotein. Int J Pharm 175(1):9–1610.1016/S0378-5173(98)00215-4 ↗
48. Carvalho FC et al (2010) Mucoadhesive drug delivery systems. Braz J Pharm Sci 46:1–1710.1590/S1984-82502010000100002 ↗
49. Peppas NA, Sahlin JJ (1996) Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 17(16):1553–156110.1016/0142-9612(95)00307-X ↗
50. Pridgen EM, Alexis F, Farokhzad OC (2015) Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv 12(9):1459–147310.1517/17425247.2015.1018175 ↗
51. Longer MA, Ch’Ng HS, Robinson JR (1985) Bioadhesive polymers as platforms for oral controlled drug delivery III: oral delivery of chlorothiazide using a bioadhesive polymer. J Pharm Sci 74(4):406–41110.1002/jps.2600740408 ↗
52. Lee JW, Park JH, Robinson JR (2000) Bioadhesive-based dosage forms: the next generation. J Pharm Sci 89(7):850–86610.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G ↗
53. Harding SE et al (1999) Biopolymer mucoadhesives. Biotechnol Genet Eng Rev 16(1):41–8610.1080/02648725.1999.10647971 ↗
54. Smart J, Kellaway I, Worthington H (1984) An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol 36(5):295–29910.1111/j.2042-7158.1984.tb04377.x ↗
55. Ben-Zion O, Nussinovitch A (1997) Physical properties of hydrocolloid wet glues. Food Hydrocolloids 11(4):429–44210.1016/S0268-005X(97)80041-0 ↗
56. Roldo M et al (2004) Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation. Eur J Pharm Biopharm 57(1):115–12110.1016/S0939-6411(03)00157-7 ↗
57. Nezhad-Mokhtari P, Ghorbani M, Mahmoodzadeh F (2019) Smart co-delivery of 6-mercaptopurine and methotrexate using disulphide-based PEGylated-nanogels for effective treatment of breast cancer. New J Chem 43(30):12159–1216710.1039/C9NJ02470K ↗
58. Takeuchi H, Yamamoto H, Kawashima Y (2001) Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev 47(1):39–5410.1016/S0169-409X(00)00120-4 ↗
59. Lehr C (1996) From sticky stuff to sweet receptors—achievements, limits and novel approaches to bioadhesion. Eur J Drug Metab Pharmacokinet 21(2):139–14810.1007/BF03190262 ↗
60. Florence AT et al (1995) Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Release 36(1–2):39–4610.1016/0168-3659(95)00059-H ↗
61. Sonaje K et al (2009) In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30(12):2329–233910.1016/j.biomaterials.2008.12.066 ↗
62. Luo Y (2020) Food colloids binary and ternary nanocomplexes: innovations and discoveries. Colloids Surf, B 196:11130910.1016/j.colsurfb.2020.111309 ↗
63. Luo Y (2020) Perspectives on important considerations in designing nanoparticles for oral delivery applications in food. Journal of Agriculture and Food Research 2:10003110.1016/j.jafr.2020.100031 ↗
64. Dünnhaupt S et al (2011) Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Int J Pharm 408(1–2):191–19910.1016/j.ijpharm.2011.01.060 ↗
65. Pauluk D et al (2019) Chitosan-coated zein nanoparticles for oral delivery of resveratrol: formation, characterization, stability, mucoadhesive properties and antioxidant activity. Food Hydrocolloids 94:411–41710.1016/j.foodhyd.2019.03.042 ↗
66. Jackson S et al (2000) Effect of resin surface charge on gastric mucoadhesion and residence of cholestyramine. Int J Pharm 205(1–2):173–18110.1016/S0378-5173(00)00500-7 ↗
67. Coupe AJ, Davis SS, Wilding IR (1991) Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res 8(3):360–36410.1023/A:1015849700421 ↗
68. Prego C et al (2005) Transmucosal macromolecular drug delivery. J Control Release 101(1–3):151–16210.1016/j.jconrel.2004.07.030 ↗
69. Cui F, Qian F, Yin C (2006) Preparation and characterization of mucoadhesive polymer-coated nanoparticles. Int J Pharm 316(1–2):154–16110.1016/j.ijpharm.2006.02.031 ↗
70. Sarmento B et al (2007) Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 24(12):2198–220610.1007/s11095-007-9367-4 ↗
71. Kararli TT (1995) Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16(5):351–38010.1002/bdd.2510160502 ↗
72. Xiao B, Merlin D (2012) Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opin Drug Deliv 9(11):1393–140710.1517/17425247.2012.730517 ↗
73. Yan Y et al (2020) Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis. Carbohyd Polym 246:11666010.1016/j.carbpol.2020.116660 ↗
74. Alexis F et al (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5(4):505–51510.1021/mp800051m ↗
75. He C et al (2012) Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. Biomaterials 33(33):8569–857810.1016/j.biomaterials.2012.07.063 ↗
76. Asane G et al (2008) Polymers for mucoadhesive drug delivery system: a current status. Drug Dev Ind Pharm 34(11):1246–126610.1080/03639040802026012 ↗
77. Khare AR et al (1992) Measurement of the swelling force in ionic polymeric networks I. Effect of pH and ionic content. J Control Release 22(3):239–24410.1016/0168-3659(92)90098-C ↗
78. Silberberg-Bouhnik M et al (1995) Osmotic deswelling of weakly charged poly (acrylic acid) solutions and gels. J Polym Sci, Part B: Polym Phys 33(16):2269–227910.1002/polb.1995.090331612 ↗
79. Inoue T et al (1998) A hydrophobically modified bioadhesive polymeric carrier for controlled drug delivery to mucosal surfaces. J Bioact Compat Polym 13(1):50–6410.1177/088391159801300105 ↗
80. Shojaei AH, Paulson J, Honary S (2000) Evaluation of poly (acrylic acid-co-ethylhexyl acrylate) films for mucoadhesive transbuccal drug delivery: factors affecting the force of mucoadhesion. J Control Release 67(2–3):223–23210.1016/S0168-3659(00)00216-9 ↗
81. Martin L et al (2003) Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. Eur J Pharm Biopharm 55(1):35–4510.1016/S0939-6411(02)00118-2 ↗
82. Jabbari E, Nozari S (2000) Swelling behavior of acrylic acid hydrogels prepared by γ-radiation crosslinking of polyacrylic acid in aqueous solution. Eur Polymer J 36(12):2685–269210.1016/S0014-3057(00)00044-6 ↗
83. Harding SE (2006) Trends in muco-adhesive analysis. Trends Food Sci Technol 17(5):255–26210.1016/j.tifs.2005.12.007 ↗
84. Makhlof A, Tozuka Y, Takeuchi H (2011) Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 42(5):445–45110.1016/j.ejps.2010.12.007 ↗
85. Chen M-C et al (2011) Chitosan: its applications in drug-eluting devices. Chitosan for Biomaterials I:185–23010.1007/12_2011_116 ↗
86. Thanou M, Verhoef J, Junginger H (2001) Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev 52(2):117–12610.1016/S0169-409X(01)00231-9 ↗
87. Hassan EE, Gallo JM (1990) A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm Res 7(5):491–49510.1023/A:1015812615635 ↗
88. Kotze A et al (1999) Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments. Eur J Pharm Sci 7(2):145–15110.1016/S0928-0987(98)00016-5 ↗
89. Shaikh RP et al (2010) A review of multi-responsive membranous systems for rate-modulated drug delivery. AAPS PharmSciTech 11(1):441–45910.1208/s12249-010-9403-2 ↗
90. Chen S, Zhu H, Luo Y (2022) Chitosan-based oral colon-specific delivery systems for polyphenols: recent advances and emerging trends. J Mater Chem B10.1039/D2TB00874B ↗
91. Sonaje K et al (2012) Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol Pharm 9(5):1271–127910.1021/mp200572t ↗
92. Chen M-C et al (2013) Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Deliv Rev 65(6):865–87910.1016/j.addr.2012.10.010 ↗
93. Severino P et al (2019) Alginate nanoparticles for drug delivery and targeting. Curr Pharm Des 25(11):1312–133410.2174/1381612825666190425163424 ↗
94. Gombotz WR, Wee S (1998) Protein release from alginate matrices. Adv Drug Deliv Rev 31(3):267–28510.1016/S0169-409X(97)00124-5 ↗
95. Netsomboon K Bernkop-Schnürch A (2016) Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur J Pharm Biopharm 98:76–8910.1016/j.ejpb.2015.11.003 ↗
96. Cho WJ, Oh SH, Lee JH (2010) Alginate film as a novel post-surgical tissue adhesion barrier. J Biomater Sci Polym Ed 21(6–7):701–71310.1163/156856209X435835 ↗
97. Davidovich-Pinhas M, Bianco-Peled H (2011) Alginate–PEGAc: a new mucoadhesive polymer. Acta Biomater 7(2):625–63310.1016/j.actbio.2010.09.021 ↗
98. Cao L et al (2020) Egg-box model-based gelation of alginate and pectin: a review. Carbohyd Polym 242:11638910.1016/j.carbpol.2020.116389 ↗
99. Pal D, Nayak AK (2012) Novel tamarind seed polysaccharide-alginate mucoadhesive microspheres for oral gliclazide delivery: in vitro–in vivo evaluation. Drug Delivery 19(3):123–13110.3109/10717544.2012.657717 ↗
100. Abasalizadeh F et al (2020) Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting. J Biol Eng 14(1):1–2210.1186/s13036-019-0223-y ↗